Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) Stock Price History
Historical prices from 2025 to 2026
Loading 10-year price history...
DMAA Historical Performance
Short-Term Returns
DMAA Stock Price Trajectory (2025–2026)
As of May 8, 2026, Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) trades at $10.60, representing a +5.0% return over the past year. The stock has delivered a +6.4% total return over five years (+1.3% CAGR), reflecting significant long-term value creation.
The stock reached its all-time high of $10.60 on May 6, 2026. From this peak, DMAA has corrected -0.0%, currently trading 2% above its 200-day moving average, indicating continued institutional support.
When compared to Financial Services sector peers HCAI (-94.7% 1Y), BRTX (-88.7% 1Y), and NUVB (+128.1% 1Y), DMAA has underperformed the peer group average. Compare DMAA vs HCAI →
DMAA Historical Price Data (2025–2026)
Showing 30 of 303 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-08 | 10.57 | 10.60 | 10.57 | 10.60 | 46K | 0.00% |
| 2026-05-07 | 10.57 | 10.60 | 10.57 | 10.60 | 21K | 0.00% |
| 2026-05-06 | 10.60 | 10.60 | 10.57 | 10.60 | 14K | +0.19% |
| 2026-05-05 | 10.56 | 10.60 | 10.56 | 10.58 | 2K | +0.09% |
| 2026-05-04 | 10.57 | 10.57 | 10.57 | 10.57 | 189 | 0.00% |
| 2026-05-01 | 10.53 | 10.57 | 10.53 | 10.57 | 406 | +0.38% |
| 2026-04-30 | 10.58 | 10.58 | 10.53 | 10.53 | 2K | -0.28% |
| 2026-04-29 | 10.56 | 10.57 | 10.55 | 10.56 | 11K | 0.00% |
| 2026-04-28 | 10.57 | 10.57 | 10.56 | 10.56 | 543 | -0.05% |
| 2026-04-27 | 10.56 | 10.57 | 10.56 | 10.56 | 2K | +0.19% |
| 2026-04-24 | 10.56 | 10.56 | 10.54 | 10.54 | 1K | +0.05% |
| 2026-04-23 | 10.54 | 10.55 | 10.54 | 10.54 | 70K | +0.00% |
| 2026-04-22 | 10.55 | 10.55 | 10.53 | 10.54 | 352K | 0.00% |
| 2026-04-21 | 10.54 | 10.55 | 10.52 | 10.54 | 559K | +0.09% |
| 2026-04-20 | 10.53 | 10.54 | 10.53 | 10.53 | 328K | 0.00% |
| 2026-04-17 | 10.54 | 10.54 | 10.53 | 10.53 | 272K | -0.09% |
| 2026-04-16 | 10.55 | 10.55 | 10.54 | 10.54 | 250K | 0.00% |
| 2026-04-15 | 10.54 | 10.54 | 10.53 | 10.54 | 2.91M | +0.19% |
| 2026-04-14 | 10.52 | 10.52 | 10.52 | 10.52 | 105 | +0.05% |
| 2026-04-13 | 10.52 | 10.52 | 10.52 | 10.52 | 0 | -0.02% |
| 2026-04-10 | 10.52 | 10.52 | 10.52 | 10.52 | 0 | -0.00% |
| 2026-04-09 | 10.52 | 10.52 | 10.52 | 10.52 | 15 | +0.03% |
| 2026-04-08 | 10.51 | 10.52 | 10.51 | 10.52 | 425K | +0.05% |
| 2026-04-07 | 10.51 | 10.52 | 10.51 | 10.51 | 47K | 0.00% |
| 2026-04-06 | 10.51 | 10.53 | 10.51 | 10.51 | 314K | 0.00% |
| 2026-04-02 | 10.51 | 10.51 | 10.49 | 10.51 | 41K | +0.10% |
| 2026-04-01 | 10.49 | 10.51 | 10.49 | 10.50 | 174 | 0.00% |
| 2026-03-31 | 10.49 | 10.50 | 10.49 | 10.50 | 12 | +0.19% |
| 2026-03-30 | 10.49 | 10.49 | 10.48 | 10.48 | 8K | -0.19% |
| 2026-03-27 | 10.50 | 10.50 | 10.50 | 10.50 | 55 | -0.10% |
See DMAA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs DMAA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare DMAA vs BRK-A
Side-by-side business, growth, and profitability comparison vs Berkshire Hathaway Inc..
Start ComparisonDMAA — Frequently Asked Questions
Quick answers to the most common questions about buying DMAA stock.
How has DMAA stock performed recently?
DMAA returned +5.0% over the past year, beating its 5-year annualized CAGR of +1.3%. The stock trades above its 200-day moving average, confirming the uptrend.
What is DMAA's all-time high price?
Drugs Made In America Acquisition Corp. Ordinary Shares reached $10.60 on 2026-05-06. The 52-week high is $10.60. Current 1-year return of +5.0% places the stock closer to historical peaks.
Where can I download DMAA historical price data?
This page provides DMAA daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2025-2026, downloadable in CSV format.